CitationCount for Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Global Citation Count uri icon

has global count value

  • 6

has global count date

  • September 25, 2025